new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Sanofi aventis Deutschland Gmbh
Sanofi
Sanofi aventis
Sanofi Pasteur
Sanofi Sa
Sanofi Pasteur Biologics Llc
Sanofi Pasteur Biologics Co
Sanofi Pasteur Sa
Sanofi Pasteur Limited
Sanofi aventis U s Llc
Sanofi Pasteur Inc
Sanofi Pasteur Vaxdesign Corporation
Sanofii aventis Deutschland Gmbh
Sanofi Biotechnology
Sanofi Pasteur Ltd
Sanofi avents Deutschland Gmbh
Sanofi Pasteur Vaxdesign Corp
Sanofi Pasteur S a
Sanofi Pasteur Limited sanofi Pasteur Limitee
Sanofi aventis Detuschland Gmbh
Sanofi aventis Deutschland
Sanofiaventis Deutschland Gmbh
Sanofi avenits Deutschland Gmbh
Sanofi aventis Deutuschland Gmbh
Sanofi aventid Deutschland Gmbh
  

Sanofi patents

Recent patent applications related to Sanofi. Sanofi is listed as an Agent/Assignee. Note: Sanofi may have other listings under different names/spellings. We're not affiliated with Sanofi, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Sanofi-related inventors




Date Sanofi patents (updated weekly) - BOOKMARK this page
11/13/14Storage device for single-use needle assemblies
08/21/14Assembly for a drug delivery device
09/26/13Drug delivery device and sequentially delivering at least two medicaments
09/12/13Ophthalmic drug delivery device with a medicated module
08/08/13Force transmission arrangement for auto-injector
01/02/14Device and detecting an actuation action performable with a medical device
11/21/13Auto-injector
04/20/17Compositions comprising anti-cd38 antibodies and carfilzomib
04/20/17Assembly for a drug delivery device
04/20/17Control of carbon dioxide levels and ph in small volume reactors
03/30/17Nanocapsular formulation of active pharmaceutical ingredients
03/23/17A novel soluble biomarker for insulin resistance
03/09/17Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays
03/02/17Novel therapeutic use of p75 receptor antagonists
03/02/17Antitumor combinations containing antibodies recognizing specifically cd38 and cyclophosphamide
02/23/17Dotam derivatives for therapeutic use
02/16/17Display arrangement for an injection device
02/16/17Humanized anti-cxcr5 antibodies, derivatives thereof and their uses
02/09/17Substituted 2-(chroman-6-yloxyl)-thiazoles and their use as pharmaceuticals
02/02/17Substituted indanone compounds as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
02/02/17Fusion molecules
02/02/17Uses of a dual v region antibody-like protein
01/26/17Isoindolinone compounds as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
01/26/17Substituted fused heterocycles as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
01/26/17Exendin-4 peptide analogues as dual glp-1/glucagon receptor agonists
01/19/17Packaging enclosing lozenge products and blank for obtaining said packaging
01/12/17Exendin-4 derivatives as selective peptidic dual glp-1/glucagon receptor agonists
12/29/16Whole-cell system for cytochrome p450 monooxygenases biocatalysis
12/22/16Assembly for a drug delivery device
12/22/16Antibodies to kallidin and des-arg9-kallidin
12/22/16Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
12/01/16Use of anti-muc1 maytansinoid immunoconjugate antibody for the treatment of solid tumors
11/24/16Solid pharmaceutical compositions containing benzofuran derivatives
11/24/16Long-acting formulations of insulin
11/10/16Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase
10/27/16Polysaccharides comprising two antithrombin iii-binding sites, preparation thereof and use thereof as antithrombotic medicaments
10/27/16Glucopyranosyl lipid a and allergen formulations for sublingual administration
10/27/16Cap for a medicament container
10/27/16Oxindole derivatives, preparation thereof and therapeutic use in the treatment of ampk-related diseases
10/13/16Drive assembly for a drug delivery device and drug delivery device comprising a drive assembly
09/29/16Pharmaceutical composition for treating a metabolic syndrome
09/29/16Drive mechanism and injection device herewith
09/29/16Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof
09/22/16Drive assembly for a drug delivery device and drug delivery device comprising a drive assembly
09/22/16Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
09/22/16Process for preparation of dronedarone by oxidation of a hydroxyl group
09/08/16H3 receptor antagonist for use in the treatment of alzheimer's disease
09/08/16Invention
09/01/16Macrocyclic urea and sulfamide derivatives as inhibitors of tafia
08/25/16Method for preparing 6-alkylated steroidal derivatives and corresponding alkylated 5,6,7,8-tetrahydronaphthalene-2(4 alpha.h)-ones
08/18/164-[5-(3-chloro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid for use in the prevention or treatment of acute kidney injury
08/18/163-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/11/16Long-acting formulations of insulin
08/04/16Exendin-4 derivatives as dual glp1/glucagon agonists
08/04/16Drive mechanism for a drug delivery device
08/04/16Heteroaryl compounds and uses thereof
07/28/16Drive mechanism for a drug delivery device
07/28/16Small volume bioreactors with substantially constant working volumes and associated systems and methods
07/21/16Pen type drug injection device with dose limiting nut to prevent setting of a dose higher than the amount of drug remaining
07/21/16Pen-type drug injection device with dose setting and re-setting mechanism
07/21/16Mechanism for a drug delivery device and drug delivery device comprising the mechanism
07/21/16Drive mechanism and injection device herewith
07/21/16Safety device for a medicament container
07/14/16Aniline derivatives, their preparation and their therapeutic application
07/14/16Mechanism for a drug delivery device and drug delivery device comprising the mechanism
Patent Packs
07/14/16Piston rod for a drug delivery device and drug delivery device comprising a piston rod
07/14/16Dual variable region antibody-like binding proteins having cross-over binding region orientation
07/14/16Antibodies to plasminogen activator inhibitor-1 (pai-1) and uses thereof
07/07/16Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor
07/07/16Drive mechanism for a drug delivery device
07/07/16Drug delivery device
07/07/16Mechanism for a drug delivery device and drug delivery device comprising the mechanism
07/07/16Drive mechanism for a drug delivery device
07/07/16Dose indicating mechanism for a drug delivery device
07/07/16Drive assembly for a drug delivery device
07/07/16Fusion proteins comprising fgf-21 and glp-1r agonist
06/30/16Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
06/23/16N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals
06/23/16Driving configuration for a drug delivery device
06/23/16Peptide or peptide complex binding to alpha2 integrin and methods and uses involving the same
Patent Packs
06/16/16Indicator and delivery device
06/16/16Drug delivery device
06/16/16Exendin-4 peptide analogues as dual glp-1/glucagon receptor agonists
06/09/16Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
06/09/16Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation
06/09/16Display assembly and dispensing device
06/09/16Priming configuration for a medical device and drug delivery device comprising a priming configuration
06/09/16Drive mechanism
06/09/16Drug delivery device
06/09/16Assembly for a drug delivery device and operating the same
06/09/16Drive mechanism for a delivery device
06/09/16Fused pyrroledicarboxamides and their use as pharmaceuticals
06/02/16Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis
06/02/16Drug delivery device
06/02/16Drug delivery device
06/02/16Drive assembly for a drug delivery device
06/02/16Drive mechanism
06/02/16Drug delivery device
06/02/16Indication assembly
05/26/16Drive mechanism for a drug delivery device
05/26/16Counting mechanism for a drug delivery device
05/19/16Drug delivery device
05/19/16Macrocyclic urea derivatives as inhibitors of tafia, their preparation and their use as pharmaceuticals
05/19/16Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
05/12/16Pyrazolopyridine derivatives for use in the treatment of bladder cancer
04/21/16Anti-ceacam5 antibodies and uses thereof
04/14/16H3 receptor antagonist for use in the treatment of alzheimer's disease
04/14/16Tartrate salt of 5-chloro-thiophene-2-carboxylic acid [(s)-2-[methyl-3-(2-oxo-pyrrolidin-1-yl)-benzenesulfonylamino]-3-(4-methyl-piperazin-1-yl)-3-oxo-propyl]amide
03/24/16Automatic drug injection device with reverse wound flat spiral spring drive mechanism
03/24/16Continuous multistep process for purifying antibodies
Social Network Patent Pack
03/17/16Injection device
03/17/16Drive mechanism of a drug delivery device
03/17/16Process for preparation of dronedarone by the use of dibutylaminopropanol reagent
03/17/16Process for preparation of dronedarone by removal of hydroxyl group
03/17/16Anti-il-4/anti-il-13 bispecific antibody formulations
03/10/16Animal model expressing luciferase under control of the myelin basic protein promoter (mbp-luci) and use of the model for bioluminescence in vivo imaging
03/10/16Display assembly for a drug delivery device
03/10/16Injection device
03/10/16Drive mechanism of a drug delivery device
03/10/16Drive mechanism for a drug delivery device
Patent Packs
03/10/16Drive mechanism of a drug delivery device
03/10/16Automatic drug injection device with sophisticated drive mechanism
03/10/16Injection device
03/10/16Injection device
03/10/16Dispensing speed control mechanism and injection device
03/03/16Drive mechanism for a drug delivery device
03/03/16Injection device
03/03/16Pen-type drug injection device and dose setting limiter mechanism therefor
03/03/16Substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them
03/03/16Pyrazolonaphthyridinone derivatives as metap2 inhibitors (methionine aminopeptidase type-2)
02/25/16Injection device
02/25/16Injection device
02/25/16Injection device
02/25/16Injection device
02/25/16Injection device
02/25/16Injection device
02/18/16Drive mechanism of a drug delivery device
02/18/16Drive assembly for a drug delivery device
02/18/16Drive mechanism for a drug delivery device
02/18/16Drive mechanism for a drug delivery device
02/18/16Drive mechanism for a drug delivery device
02/18/16Drive mechanism for a drug delivery device
02/18/16Drive mechanism for a drug delivery device
02/18/16Injection device and assembly method
02/18/16Hand-held drug injection device and dose setting limiter mechanism therefor
02/18/16Dispensing speed control mechanism and injection device
02/18/16Heteroaryl compounds and uses thereof
02/11/16Injection device
02/04/16Treatment of diabetes mellitus by long-acting formulations of insulins
02/04/16Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients
Patent Packs
02/04/16Anti-tumoral composition comprising a pi3kbeta inhibitor and a raf inhibitor, to overcome cancer cells resistance
02/04/16Anti-tumoral composition comprising a pi3kbeta-selective inhibitor and a pi3kalpha-selective inhibitor
02/04/16Drive mechanism of a drug delivery device
02/04/16Injection device
01/28/16Compositions comprising anti-cd38 antibodies and carfilzomib
01/28/16Macrocyclic urea and sulfamide derivatives as inhibitors of tafia
01/28/16N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals
01/21/16Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
01/14/16Process for preparation of dronedarone by oxidation of a hydroxyl group
01/14/16Process for preparation of dronedarone by n-butylation
01/07/16Serpins: methods of therapeutic beta-cell regeneration and function
12/31/15Chewable composition for oral administration and process for preparing thereof
12/24/15Serpins: methods of therapeutic b-cell regeneration and function
12/24/15Exendin-4 derivatives as selective glucagon receptor agonists
12/24/15Method t0 make an aqueous pour point depressant dispersion composition
12/10/15Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
12/03/15Novel 6-triazolopyridazine sulfanyl benzothiazole derivatives as met inhibitors
12/03/15Intracellular phenotypic screening
11/26/15Isomannide derivatives as inhibitors of soluble epoxide hydrolase
11/19/15Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
Social Network Patent Pack
11/19/152-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
11/12/15Method of preparation of crystal forms of 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxidopyridyn-4-yl)-5-methoxypyridine-2-carboxamide and cristal forms thereof
11/12/15Dual glp-1/glucagon receptor agonists derived from exendin-4
11/12/15Peptidic dual glp-1/glucagon receptor agonists derived from exendin-4
11/05/15Solid unit with high fexofenadine content and process for the preparation thereof
11/05/15Exendin-4 derivatives as peptidic dual glp-1/glucagon receptor agonists
10/29/15Process for preparing 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide
10/15/15Method for preparing phenyloxymethyl-nitro-imidazole derivatives and use of same
10/08/15Fluorescence-labelled fatty acids and uses thereof
10/01/15Medicament container carrier
10/01/15Process for preparation of dronedarone by grignard reaction
10/01/151h-indole-3-carboxamide derivatives and use thereof as p2y12 antagonists
10/01/15Method for recombinant production of labyrinthopeptins and functional derivatives thereof
10/01/15Nanopillar field-effect and junction transistors with functionalized gate and base electrodes
10/01/15Nanopillar field-effect and junction transistors with functionalized gate and base electrodes
09/24/15Anti-cancer compound and pharmaceutical composition containing the same
09/03/15Tablet formulation of a phosphatidylinositol 3-kinase inhibitor
09/03/15Methods for treating or preventing asthma by administering an il-4r antagonist
09/03/15Methods for treating skin infection by administering an il-4r antagonist
08/20/15Pharmaceutical composition for treating a metabolic syndrome
Social Network Patent Pack
08/20/15Methods for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapy
08/20/15Anti-alpha2 integrin antibodies and their uses
08/13/15Anti-il-4/anti-il-13 bispecific antibody/polyglutamate formulations
08/06/15Article of manufacture comprising aflibercept or ziv-aflibercept
08/06/15Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
08/06/15Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
07/30/15Transgenic non-human animal and uses thereof
07/30/15Macrolide derivatives, preparation thereof and therapeutic use thereof
07/30/15Anti-poly-n-acetyl glucosamine (pnag) monoclonal antibody and uses thereof for the prevention or treatment of pnag expressing bacterial infection
07/23/15Otamixaban for use in the treatment of non-st elevation acute coronary syndrome in patients planned to undergo coronary artery bypass grafting
07/16/15Pharmaceutical composition and dosage form comprising dronedarone, and preparation method thereof
07/09/15Stabilized pharmaceutical formulations of insulin aspart
07/02/15Safety assembly for a syringe
07/02/15Crystalline compounds
07/02/15Use of vegfr-3 inhibitors for treating hepatocellular carcinoma
07/02/15Pyrimidinone derivatives as antimalarial agents
06/18/15Exendin-4 peptide analogues as dual glp-1/gip agonists
06/18/15Non-acylated exendin-4 peptide analogues
06/18/15Dual glp-1/glucagon receptor agonists
06/18/15Long-acting formulations of insulin
06/18/15Exendin-4 peptide analogues
06/18/15Dual glp-1/gip receptor agonists
06/04/15Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis
06/04/15Dosing regimens for use with pcsk9 inhibitors
05/28/15Novel 2,3-dihydro-1h-imidazopyrimidin-5-one and this 1,2,3,4-tetrahydropyrimidopyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof
05/21/15Unitary packaging for one container filled with a liquid pharmaceutical product
05/21/15Use of a pcsk9 inhibitor to treat hyperlipidemia
05/21/15Cho expression system
05/21/15Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
05/21/15Pyrazole derivatives and their use as lpar5 antagonists
Social Network Patent Pack
05/14/15Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
04/30/15Specific anti-cd38 antibodies for treating human cancers
04/30/15Stable formulation of insulin glulisine
04/30/15Anti-tumoral composition comprising the compound 1-(6--1,3-benzothiazol-2-yl)-3-(2-morpholin-4-ylethyl)urea
04/23/15Method for producing recombinant 11-de-o-methyltomaymycin
04/23/15Benzo[1,3]dioxine derivatives and their use as lpar5 antagonists
04/09/15Novel antagonist antibodies and their fab fragments against gpvi and uses thereof
04/09/15Methods for the activation of silent genes in a microorganism
04/02/15Use of neuroglobin agonist for preventing or treating mitochondrial rcci and/or rcciii deficiency disease
03/26/15Methods for preventing biofilm formation
03/26/15Subsituted 2-(chroman-6-yloxyl)-thiazoles and their use as pharmaceuticals
03/12/15Mixture of polar glycolipids for use in the treatment of pain and copd
03/12/15Substituted b-amino acid derivatives as cxcr3 receptor antagonists
03/05/15Compositions and methods for analyzing histidine phosphorylation
03/05/15Basal insulin therapy
03/05/15Use of vgii3 activity modulator for the modulation of adipogenesis
02/26/15Use of inhibitors of zdhhc2 activity for modulation of adipogenesis
02/19/15Antibodies to bradykinin b1 receptor ligands
02/12/15Antibodies that specifically bind to the epha2 receptor
02/05/15Functional pla-peg copolymers, the nanoparticles thereof, their preparation and use for targeted drug delivery and imaging
01/29/15Methods for treating cancer using pi3k inhibitor and mek inhibitor
01/29/15An h3 receptor antagonist for use in the treatment of alzheimer's disease
01/29/15Method for preparing 5-amino-benzofuran derivatives
01/29/15Process for the preparation of dronedarone by oxidation of a sulphenyl group
01/15/15Methods for treating nasal polyposis by administering an il-4r antagonist
01/15/15Fused pyrroledicarboxamides and their use as pharmaceuticals
01/15/15Process for the preparation of enantiomeric forms of 2,3-diaminopropionic acid derivatives
01/15/15Process for preparation of dronedarone by the use of dibutylaminopropanol reagent
01/08/15Fgf receptor (fgfr) agonist dimeric compounds, process for the preparation thereof and therapeutic use thereof







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Sanofi in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sanofi with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';